EP 1161442 A2 20011212 - EXOCYTOSIS PATHWAY PROTEINS AND METHODS OF USE
Title (en)
EXOCYTOSIS PATHWAY PROTEINS AND METHODS OF USE
Title (de)
EXOCYTOSE-WEG PROTEINE UND VERFAHREN ZU DERER VERWENDUNG
Title (fr)
PROTEINE DE VOIES D'EXOCYTOSE ET LEURS PROCEDES D'UTILISATION
Publication
Application
Priority
- US 0001431 W 20000120
- US 11653499 P 19990120
- US 11727499 P 19990126
- US 11730899 P 19990126
- US 11731299 P 19990126
- US 11730999 P 19990126
- US 11817899 P 19990201
- US 11817999 P 19990201
- US 11817799 P 19990201
- US 11928699 P 19990209
- US 11999899 P 19990211
- US 11975999 P 19990211
Abstract (en)
[origin: WO0043419A2] The present invention is directed to novel polypeptides such as the Exo protein and related molecules which have an effect on or are related to exocytosis and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are method for identifying novel compositions which mediated Exo bioactivity, and the use of such compositions in diagnosis and treatment of disease.
IPC 1-7
IPC 8 full level
G01N 33/50 (2006.01); A61K 31/7125 (2006.01); A61K 35/12 (2015.01); A61K 35/742 (2015.01); A61K 35/76 (2015.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 3/10 (2006.01); A61P 11/06 (2006.01); A61P 15/08 (2006.01); A61P 15/14 (2006.01); A61P 17/02 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01)
CPC (source: EP)
A61P 3/10 (2017.12); A61P 11/06 (2017.12); A61P 15/08 (2017.12); A61P 15/14 (2017.12); A61P 17/02 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07K 14/435 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0043419A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0043419 A2 20000727; WO 0043419 A3 20010215; AU 2416600 A 20000807; CA 2359145 A1 20000727; EP 1161442 A2 20011212; JP 2003521230 A 20030715
DOCDB simple family (application)
US 0001431 W 20000120; AU 2416600 A 20000120; CA 2359145 A 20000120; EP 00902456 A 20000120; JP 2000594835 A 20000120